AI-driven demand is fueling LITE's laser chips and optical transceivers, with over 60% of revenues tied to AI infrastructure and cloud growth.

Bristol-Myers Squibb remains a contrarian dividend Buy, despite the overbought technical indicators and growth headwinds.

The Toro Company’s third quarter was met with a positive market reaction, as management cited improved execution in its Professional segment and better-than-expected results from snow and underground ...

Discover why Abbott Laboratories (ABT) earns a buy rating with strong fundamentals, dividend growth, and growth prospects.